Search clinical trials for: IN-R00007

Total 10000 results

HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult Volunteers

Healthy Volunteers

South Korea
HK inno.N Corporation

Active, not recruiting

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

Non-valvular Atrial Fibrillation (NVAF)

Korea, Republic of
HK inno.N Corporation

Not yet recruiting

Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

Diabetes Mellitus Type 2 | Diabetes (DM)
HK inno.N Corporation

Not yet recruiting

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

Obesity &Amp; Overweight
Federico II University
Friedreich's Ataxia Research Alliance; Associazione Italiana per la lotta alle...

Completed

Efficacy Study of Epoetin Alfa in Friedreich Ataxia (FRIEMAX)

Friedreich Ataxia

Italy
Redx Pharma Plc
Simbec-Orion Group

Active, not recruiting

Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

Fibrosis | IPF

Spain, United Kingdom, Belgium, Italy, Austria, Czechia, Poland, Switzerland
Redx Pharma Plc
Simbec Research

Completed

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Liver Diseases | Fibrosis | Kidney Diseases | Inflammation | Idiopathic Pulmonary Fibrosis | Non-alcoholic Steatohepatitis

United Kingdom
Pierre Fabre Medicament

Completed

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

Breast Cancer

France, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

Healthy Volunteer

South Korea
3H Pharmaceuticals Co., Ltd.

Recruiting

A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors

Stomach Cancer | Lung Cancer

China
Pierre Fabre Medicament

Completed

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Breast Cancer | Metastases

France, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
Guangdong Center for Disease Prevention and Control

Unknown

Effects of Brisk Walking on Overweight/Obesity Population

Obesity
Medical University of South Carolina

Completed

Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems

Cataract Extraction
Novo Nordisk A/S

Completed

A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

United Kingdom, Romania, Poland, Denmark, Czech Republic, Hungary
Celgene

No longer available

Expanded Access for AG-221

Acute Myeloid Leukemia

United States
Novo Nordisk A/S

Completed

Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects

Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

United Kingdom
Sichuan Huiyu Pharmaceutical Co., Ltd

Recruiting

Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

Efficacy | Tolerability | Safety

China
Novo Nordisk A/S

Completed

Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects

Inflammation | Healthy | Rheumatoid Arthritis | Systemic Lupus Erythematosus

Netherlands
Novo Nordisk A/S

Withdrawn

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

Inflammation | Systemic Lupus Erythematosus

United States
Janssen Research & Development, LLC

Completed

A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)

Infarction | Ischemia | Stroke

United States
University of Cincinnati
Medical University of South Carolina; Celgene Corporation

Completed

The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis

Sarcoidosis | Cutaneous Sarcoidosis

United States
Novo Nordisk A/S

Completed

First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis

Inflammation | Healthy | Rheumatoid Arthritis

Germany
Peregrine Eye and Laser Institute
Alcon Research

Recruiting

Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter (HYPE)

Vitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane | Vitrectomy | Macular Holes | Dislocated Intraocular Lens Into Vitreous | Retained Lens Fragments

Philippines
Janssen Research & Development, LLC

Completed

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Inflammation | Crohn's Disease

Belgium, France, Israel, Hungary, Russian Federation, Poland, Canada, United States
Innate Pharma

Completed

Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

Germany
HK inno.N Corporation

Unknown

A Study to Evaluate Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 in Healthy Male Subjects

Healthy

Korea, Republic of
Liaquat University of Medical & Health Sciences

Completed

A Comparative Dissolution and Absorption Study of an Orodispersible Powder, Chewable Tablet and Soft Gel Capsule Vitamin D3 Supplementation

Vitamin D Deficiency

Pakistan
Wahba bakhet
Bahteem Specialized Hospital

Completed

Local Anesthesia for Pediatric Cochlear Implant

Anesthesia, Local

Egypt
Clinica Valle Giulia

Unknown

Culture Media and Blastocyst Development

Embryo Development

Italy
Institute of Medical Biology, Chinese Academy of...
Guangxi Center for Disease Control and Prevention

Completed

A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants

Hand, Foot and Mouth Disease

China
University Hospital, Strasbourg, France

Completed

Light Therapy in Parkinson's Disease

Parkinson's Disease

France
Pierre Fabre Medicament

Active, not recruiting

Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer (OCEANII)

Non-Small Cell Lung Cancer

China, Taiwan
Grifols Therapeutics LLC

Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults (ChAMP)

Alpha 1-Antitrypsin Deficiency

United States
Derek Richards

Terminated

iCBT for Long-term Conditions in IAPT

Depression | Diabetes | Chronic Pain | Anxiety | COPD | CHD - Coronary Heart Disease

United Kingdom
HK inno.N Corporation

Completed

Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

Healthy

Korea, Republic of
Alexandria University

Completed

Systemic Erythropoietin Injection in Patients Having Optic Atrophy

Optic Atrophy

Egypt
Mayo Clinic

Completed

Satellite-supplementation of Medical Outreach Clinics: a Feasibility Study

Telemedicine | Primary Health Care | Diagnosis | Therapeutics | Developing Countries

Honduras
Celgene

Completed

Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment

Hepatic Impairment

United States
Centre Hospitalier Universitaire Vaudois

Unknown

Hypoxic Exercise in Lower Extremity Artery Disease

Peripheral Arterial Disease

Switzerland
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects

Healthy Adult Subjects

China
Novo Nordisk A/S

Completed

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B (paradigm™ 3)

Congenital Bleeding Disorder | Haemophilia B

United States, Netherlands, Austria, Spain, Germany, Macedonia, The Former Yugoslav Republic of, Taiwan, United Kingdom, Italy, Malaysia, Thailand, France, Greece, Turkey, Japan, South Africa, Romania
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients

Mild to Moderate Atopic Dermatitis
Xuanwu Hospital, Beijing

Recruiting

Nurse-led Clinics Training Program on Mild Cognitive Impairment Patients

Mild Cognitive Impairment

China
Celgene

Completed

A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.

Hepatic Impairment

United States
Sahlgrenska University Hospital

Completed

Descriptive and Comparative Study of Respiratory Function in the Postoperative Cardiac Surgery Patient

Pulmonary Atelectasis

Sweden
Novo Nordisk A/S

Completed

Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients (paradigm™ 2)

Congenital Bleeding Disorder | Haemophilia B

United States, Netherlands, Germany, Macedonia, The Former Yugoslav Republic of, United Kingdom, Italy, Malaysia, Hungary, Thailand, France, Russian Federation, Turkey, Japan, South Africa, Canada
Steno Diabetes Center Copenhagen

Active, not recruiting

Acute Changes in Plasma Glucose and Cardiovascular Disease in Diabetes

Hyperglycemia | Cardiovascular Diseases | Hypoglycemia | Diabetes | Sudden Cardiac Death

Denmark
Maíra F Pessoa

Completed

Oxygen Consumption After Acute Whole Body Vibration Session

Oxygen Consumption | Aged

Brazil
Silesian Centre for Heart Diseases
The Jerzy Kukuczka Academy of Physical Education in Katowice

Completed

Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients

type1diabetes

Poland
Guohua Zeng

Unknown

Dusting vs Basketing in RIRS: a Single-center Prospective Randomised Trial

Urolithiasis

China

Search clinical trials for: IN-R00007

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations